PAX3 and neoplasm: These findings indicate that PAX3-FOXO1 interacts with MYCN to promote the occurrence of RSM by inhibiting myogenic differentiation and cell death, and recurrent tumours develop in a PAX3-FOXO1-independent manner [80]..